BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16764881)

  • 21. Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients.
    Al-Daghri NM; Al-Attas OS; Bindahman LS; Alokail MS; Alkharfy KM; Draz HM; Yakout S; McTernan PG; Sabico S; Chrousos GP
    Eur J Clin Invest; 2012 Nov; 42(11):1221-6. PubMed ID: 22946776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of blood pressure and fitness with levels of atherosclerotic risk markers pre-exercise and post-exercise.
    von Känel R; Hong S; Pung MA; Mills PJ
    Am J Hypertens; 2007 Jun; 20(6):670-5. PubMed ID: 17531926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Selectins in the pathogenesis and diagnosis of early atherosclerotic changes in children and adolescents with risk factors (obesity, hypertension and diabetes)].
    Głowińska B; Urban M; Peczyńska J; Florys B
    Przegl Lek; 2004; 61(9):935-9. PubMed ID: 15803902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Nadar SK; Blann AD; Kamath S; Beevers DG; Lip GY
    J Am Coll Cardiol; 2004 Jul; 44(2):415-22. PubMed ID: 15261941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension.
    Gkaliagkousi E; Corrigall V; Becker S; de Winter P; Shah A; Zamboulis C; Ritter J; Ferro A
    Eur Heart J; 2009 Dec; 30(24):3048-54. PubMed ID: 19687162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.
    Knier B; Cordasic N; Klanke B; Heusinger-Ribeiro J; Daniel C; Veelken R; Hartner A; Hilgers KF
    J Hypertens; 2011 Aug; 29(8):1602-12. PubMed ID: 21610512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of doxazosin gastrointestinal therapeutic system on platelet degranulation and platelet-leukocyte microaggregate formation induced by physiologic shear stress in hypertension.
    Labiós M; Martínez M; Gabriel F; Guiral V; Aznar J
    Thromb Res; 2006; 118(4):447-53. PubMed ID: 16242179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
    J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of platelet activation indices using the ADVIATM 120 amongst 'high-risk' patients with hypertension.
    Boos CJ; Beevers GD; Lip GY
    Ann Med; 2007; 39(1):72-8. PubMed ID: 17364453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
    Choudhury A; Chung I; Blann AD; Lip GY
    J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoplasmic free calcium mobilization in platelets, expression of P-selectin, phosphatidylserine, and microparticle formation, measured by whole blood flow cytometry, in hypertensive patients. Effect of doxazosin GITS.
    Labiós M; Martínez M; Gabriel F; Guiral V; Ruiz-Aja S; Aznar J
    Thromb Res; 2006; 117(4):403-9. PubMed ID: 16461073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in thrombin generation, fibrinolysis, platelet and endothelial cell activity, and inflammation following endovascular abdominal aortic aneurysm repair.
    Abdelhamid MF; Davies RS; Adam DJ; Vohra RK; Bradbury AW
    J Vasc Surg; 2012 Jan; 55(1):41-6. PubMed ID: 21975058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of severe, uncontrolled hypertension on endothelial activation: soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Willebrand factor.
    Preston RA; Ledford M; Materson BJ; Baltodano NM; Memon A; Alonso A
    J Hypertens; 2002 May; 20(5):871-7. PubMed ID: 12011647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships of different blood pressure categories to indices of inflammation and platelet activity in sustained hypertensive patients with uncontrolled office blood pressure.
    Erdogan D; Icli A; Aksoy F; Akcay S; Ozaydin M; Ersoy I; Varol E; Dogan A
    Chronobiol Int; 2013 Oct; 30(8):973-80. PubMed ID: 23834704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm.
    Wanhainen A; Nilsson TK; Bergqvist D; Boman K; Björck M
    J Vasc Surg; 2007 Jun; 45(6):1109-13. PubMed ID: 17543671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive therapy regimen and platelet activation in renal transplant patients.
    Graff J; Klinkhardt U; Harder S; Wegert W; Lenz T; Scheuermann EH; Gossmann J
    Clin Pharmacol Ther; 2002 Oct; 72(4):411-8. PubMed ID: 12386643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
    Blann AD; Dobrotova M; Kubisz P; McCollum CN
    Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.